146 related articles for article (PubMed ID: 20686358)
21. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.
Suschak JJ; Williams JA; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):2837-2848. PubMed ID: 28604157
[TBL] [Abstract][Full Text] [Related]
22. Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity.
Sun B; Li ZS; Tu ZX; Xu GM; Du YQ
World J Gastroenterol; 2006 Nov; 12(43):7042-6. PubMed ID: 17109503
[TBL] [Abstract][Full Text] [Related]
23. Bacterial ghosts are an efficient delivery system for DNA vaccines.
Ebensen T; Paukner S; Link C; Kudela P; de Domenico C; Lubitz W; Guzmán CA
J Immunol; 2004 Jun; 172(11):6858-65. PubMed ID: 15153504
[TBL] [Abstract][Full Text] [Related]
24. Current status of DNA vaccines and their route of administration.
Alpar HO; Bramwell VW
Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):307-83. PubMed ID: 12661697
[TBL] [Abstract][Full Text] [Related]
25. Applications of bacterial ghosts in biomedicine.
Lubitz P; Mayr UB; Lubitz W
Adv Exp Med Biol; 2009; 655():159-70. PubMed ID: 20047041
[TBL] [Abstract][Full Text] [Related]
26. [Attenuated Salmonella typhimurium as DNA delivery vehicle for DNA-mediated immunization].
He P; Chen H; Liu JX; Chen SY; Hu BY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):238-42. PubMed ID: 15640857
[TBL] [Abstract][Full Text] [Related]
27. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
[TBL] [Abstract][Full Text] [Related]
28. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
Li R; Lim A; Alonso S
Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
[TBL] [Abstract][Full Text] [Related]
29. A novel multivalent vaccine based on secretary antigen-delivery induces protective immunity against Vibrio anguillarum and Aeromonas hydrophila.
Zhou L; Wang X; Liu Q; Wang Q; Zhao Y; Zhang Y
J Biotechnol; 2010 Mar; 146(1-2):25-30. PubMed ID: 20026209
[TBL] [Abstract][Full Text] [Related]
30. DNA vaccines: vector design, delivery, and antigen presentation.
Feltquate DM
J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
[TBL] [Abstract][Full Text] [Related]
31. Micro- and nanoparticulates for DNA vaccine delivery.
Farris E; Brown DM; Ramer-Tait AE; Pannier AK
Exp Biol Med (Maywood); 2016 May; 241(9):919-29. PubMed ID: 27048557
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant.
Li N; Yu YZ; Yu WY; Sun ZW
Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):211-9. PubMed ID: 21284488
[TBL] [Abstract][Full Text] [Related]
33. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
Jiang H; Hu Y; Yang M; Liu H; Jiang G
Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
[TBL] [Abstract][Full Text] [Related]
34. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors.
Tanghe A; Lefèvre P; Denis O; D'Souza S; Braibant M; Lozes E; Singh M; Montgomery D; Content J; Huygen K
J Immunol; 1999 Jan; 162(2):1113-9. PubMed ID: 9916741
[TBL] [Abstract][Full Text] [Related]
36. Listeria monocytogenes as novel carrier system for the development of live vaccines.
Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
[TBL] [Abstract][Full Text] [Related]
37. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
38. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
Li Z; Wang S; Wu Y; Zhong G; Chen D
Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
[TBL] [Abstract][Full Text] [Related]
39. Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
Jiao H; Yang H; Zhao D; Chen J; Zhang Q; Liang J; Yin Y; Kong G; Li G
Vaccine; 2018 Jul; 36(30):4532-4539. PubMed ID: 29914847
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
